Beijing Strong Biotechnologies, Inc. (300406.SZ) obtained a medical device registration certificate.
Jiuphar Biotech (stock code: 300406.SZ) issued an announcement on November 13, 2024, stating that the company has received a notification from the Beijing Drug...
Beijing Strong Biotechnologies, Inc. (300406.SZ) announced that on November 13, 2024, the company received the "Medical Device Registration Certificate" issued by the Beijing Municipal Drug Administration. The product name is Interleukin-6 assay kit (magnetic particles chemiluminescent immunoassay), which is used for the quantitative determination of Interleukin-6 (IL-6) in human serum or plasma.
The acquisition of the above-mentioned product medical device registration certificate enriches the company's product categories, enhances the company's core competitiveness, and has a positive impact on the company's future development.
Related Articles

New stock news | Ruiwei Technology submits documents to the Hong Kong Stock Exchange, ranking first in the Chinese civil aviation enterprise visual intelligent product market.

EB SECURITIES: Hong Kong stocks may show a volatile trend, but the long-term allocation cost-effectiveness of assets such as new consumer and innovative drugs remains relatively high.

New stock news | Zijin Gold International submitted an application to the Hong Kong Stock Exchange. As of December 31, 2024, its gold reserves ranked ninth in the world.
New stock news | Ruiwei Technology submits documents to the Hong Kong Stock Exchange, ranking first in the Chinese civil aviation enterprise visual intelligent product market.

EB SECURITIES: Hong Kong stocks may show a volatile trend, but the long-term allocation cost-effectiveness of assets such as new consumer and innovative drugs remains relatively high.

New stock news | Zijin Gold International submitted an application to the Hong Kong Stock Exchange. As of December 31, 2024, its gold reserves ranked ninth in the world.

RECOMMEND

Trump Signals End to Trade Talks, Vows to Impose Tariffs Unilaterally Ahead of July 9 Deadline
30/06/2025

One License Unlocks HKD 23.4 Billion Surge: Unpacking Hong Kong’s Ambitions as a Global Virtual Asset Hub
30/06/2025

16 Companies Submit IPO Applications in One Day; Hong Kong IPO Fundraising Hits Three-Year High
30/06/2025